INEFFECTIVE, COGNITIVE DYSFUNC

Verify with FDA CVM →

VeDDRA Code: 99092

54 adverse event reports referencing this reaction

54
Total Reports
0
Deaths
0.0%
Death Rate

Species Most Affected

Dog 54

Breeds Most Affected

Dog (unknown) 7
Crossbred Canine/dog 5
Retriever - Labrador 5
Beagle 3
Siberian Husky 3
Terrier - Fox (unspecified) 2
Schnauzer - Miniature 2
Shepherd Dog - Australian 2
Cattle Dog (unspecified) 2
Pekingese 2

Associated Drugs

Selegiline Hcl 41
Selegiline 15
Firocoxib 3
Deracoxib 2
Tramadol 2
Prescription Diet (Unspecified) 2
Fluoxetine Hydrochloride 2
Cyclosporine 2
Carprofen 2
Alprazolam 2
Famotidine 1
Phenylpropanolamine 1
Benazepril Hydrochloride 1
Trilostane 1
Levothyroxine Sodium 1
Anti-Inflamatory 1
Milbemycin Oxime + Spinosad 1
Diphenhydramine 1
Trazodone 1
Sam-E, Silybin, Vitamin E, Zinc 1

Data Summary

Metric Value
Total reports referencing reaction 54
Reports with fatal outcome 0
Case-fatality rate (reported events) 0.0%
Species observed 1
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 99092.

INEFFECTIVE, COGNITIVE DYSFUNC Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 54 adverse event reports that reference INEFFECTIVE, COGNITIVE DYSFUNC as a reaction term, including 0 reports with a death outcome — a 0.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 99092, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

INEFFECTIVE, COGNITIVE DYSFUNC appears most frequently in reports for Dog (54 reports) — with Dog dominating at 54 entries. Within those species, the breeds most often named alongside this reaction are Dog (unknown) (7), Crossbred Canine/dog (5), Retriever - Labrador (5). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with INEFFECTIVE, COGNITIVE DYSFUNC are Selegiline Hcl (41 reports), Selegiline (15 reports), Firocoxib (3 reports), Deracoxib (2 reports), with Selegiline Hcl appearing alongside this reaction in 41 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial